Caris Life Sciences, Inc. (CAI) Current Reports & Earnings Releases
Upcoming
- 2026-11-04 Earnings Release Estimated
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-08-05 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-06-05 | 8-K | Shareholder Vote Results | SEC |
| 2026-05-07 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-04-02 | 8-K | Material Agreement, Termination of Agreement, Direct Financial Obligation | SEC |
| 2026-02-26 | 8-K | Results of Operations, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-01-12 | 8-K | Results of Operations, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-11-05 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-10-30 | 8-K | Item 3.03, Charter Amendments, Financial Statements & Exhibits | SEC |
| 2025-08-12 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-06-20 | 8-K | Charter Amendments, Other Events, Financial Statements & Exhibits | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.